|Bid||0.00 x 2900|
|Ask||0.00 x 3000|
|Day's range||5.24 - 5.49|
|52-week range||4.00 - 16.37|
|Beta (5Y monthly)||N/A|
|PE ratio (TTM)||N/A|
|Earnings date||09 Nov 2021 - 15 Nov 2021|
|Forward dividend & yield||N/A (N/A)|
|1y target est||12.57|
Investors need to pay close attention to GoHealth (GOCO) stock based on the movements in the options market lately.
GoHealth (GOCO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of GoHealth, Inc. (NASDAQ: GOCO) pursuant and/or traceable to the registration statement issued in connection with GoHealth’s July 2020 initial public offering (the "IPO") of the important November 20, 2020 lead plaintiff deadline in the case. The lawsuit seeks to recover damages for GoHealth investors under the federal securities laws.